The company had net profit of Rs 23.60 crore for the corresponding quarter of 2011-12 fiscal, Ajanta Pharma said in a filing to BSE.
Net sales of the company rose to Rs 249.21 crore during the January-March quarter of 2012-13 fiscal, from Rs 168.61 crore for the same period year ago.
Also Read
In another filing to the BSE, the company said its board of directors have recommended dividend at the rate of Rs 6.25 per equity share of the face value of Rs 5 each.
Net profit of the company for the year ended March 31, 2013 stood at Rs 101.12 crore as against Rs 66.49 crore for the year ago period.
Net sales of the company for the year ended March 31, 2013 also rose to Rs 828.50 crore from Rs 591.98 crore for the corresponding period previous fiscal year.
Ajanta Pharma scrip closed at Rs 777.05 on the BSE, down 1.81% from its previous close.
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →*Subscribe to Business Standard digital and get complimentary access to The New York Times
Smart Quarterly
₹900
3 Months
₹300/Month
SAVE 25%
Smart Essential
₹2,700
1 Year
₹225/Month
SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months
Super Saver
₹3,900
2 Years
₹162/Month
Subscribe
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors
Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share
Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor
Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements
Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
SAVE 25%